Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases | RMD Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases - March 01, 2022

Infections

Letter

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases

Online download statistics by month:

Online download statistics by month: March 2022 to March 2024

	Abstract	Full	Pdf
Mar 2022	418	427	139
Apr 2022	150	149	39
May 2022	179	175	40
Jun 2022	130	144	25
Jul 2022	83	80	29
Aug 2022	66	56	11
Sep 2022	72	73	21
Oct 2022	62	58	19
Nov 2022	62	60	17
Dec 2022	40	36	7
Jan 2023	67	60	9
Feb 2023	53	46	19
Mar 2023	52	41	15
Apr 2023	22	18	9
May 2023	18	19	14
Jun 2023	30	27	11
Jul 2023	15	13	8
Aug 2023	27	23	12
Sep 2023	23	22	7
Oct 2023	21	19	2
Nov 2023	28	22	6
Dec 2023	19	20	4
Jan 2024	19	19	16
Feb 2024	17	17	12
Mar 2024	25	24	52
Total	1698	1648	543